HSHHSH Health Technology Supplier Hub

Suppliers starting with “S”

Showing 1–23 of 23

SalesforceHQ United States · North America
Patient engagement & accessPopulation health & analytics

FY2026 revenue $41.52bn (+10.0%); operating margin 20.1%; net income $7.46bn.

Cash $7.33bn; debt $14.44bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
Samsung MedisonHQ South Korea · Asia-Pacific
Imaging, PACS & RIS

Parent Samsung Electronics (005930.KS) group FY2025 revenue ₩333.60tn; operating margin 13.1%.

Group figures; net profit not stated in release.

Financial health: StrongRisk summary →
No reviews yet
View profile
SAPHQ Germany · Europe
ERP, finance & supply chain

FY2025 revenue €36.80bn (+8.0%); operating margin 26.7%; net income €7.49bn.

Net liquidity (net cash) €3.38bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
ScreenPoint MedicalHQ Netherlands · Europe
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SectraHQ Sweden · Europe
Cyber securityImaging, PACS & RIS

FY2025/26 revenue SEK 3.54bn (+9.3%); operating margin 20.1%; net income SEK 563.8m.

Prior year included a SEK 110m one-off patent settlement.

Financial health: StrongRisk summary →
No reviews yet
View profile
ShimadzuHQ Japan · Asia-Pacific
Diagnostics & IVDImaging, PACS & RIS

FY2025 revenue ¥560.7bn; operating margin 13.1%; net income ¥60.5bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
Siemens HealthineersHQ Germany · Europe
Clinical AI & decision supportDiagnostics & IVDImaging, PACS & RIS

FY2026 revenue €23.60bn; adjusted EBIT margin 16.2%.

Comparable revenue growth 4.0%; adjusted EBIT about €3.8bn. Net income not captured.

Financial health: StrongRisk summary →
No reviews yet
View profile
Smile Digital HealthHQ Canada · North America
Interoperability & integration

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Smith & NephewHQ United Kingdom · Europe
Medical devices & monitoringSurgical & theatre systems

FY2025 revenue $6.16bn (+6.1%); operating margin 12.9%; net income $625.0m.

Net debt $2.76bn including leases.

Financial health: StrongRisk summary →
No reviews yet
View profile
SolventumHQ United States · North America
Clinical AI & decision supportRevenue cycle, billing & claims

FY2025 revenue $8.32bn (+0.9%); operating margin 26.2%; net income $1.56bn.

Cash $878.0m; debt $5.04bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
SOPHiA GENETICSHQ Switzerland · Europe
Clinical AI & decision supportGenomics & precision medicine

FY2025 revenue $77.3m (+19.0%); operating margin -91.7%; net loss $79.0m.

Balance sheet figures not captured from release.

Financial health: WeakRisk summary →
No reviews yet
View profile
SophosHQ United Kingdom · Europe
Cyber security

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SpokHQ United States · North America
Clinical communications & nurse call

FY2025 revenue $139.7m (+1.5%); operating margin 14.1%; net income $15.9m.

No debt; $25.3m cash.

Financial health: StrongRisk summary →
No reviews yet
View profile
Strata Decision TechnologyHQ United States · North America
ERP, finance & supply chain

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
StrykerHQ United States · North America
Clinical communications & nurse callMedical devices & monitoringSurgical & theatre systems

FY2025 revenue $25.12bn (+11.2%); operating margin 19.5%; net income $3.25bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
SukiHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Surgical Information SystemsHQ United States · North America
Surgical & theatre systems

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Swisslog HealthcareHQ Switzerland · Europe
Pharmacy & medicines management

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Sword HealthHQ United States · North America
Digital therapeutics & appsRemote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
symplrHQ United States · North America
ERP, finance & supply chainWorkforce & rostering

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SysmexHQ Japan · Asia-Pacific
Diagnostics & IVDLaboratory & pathology (LIMS)

FY2025 revenue ¥500.0bn (-1.7%); operating margin 10.4%; net income ¥35.5bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
System CHQ United Kingdom · Europe
Electronic health records (EHR/EPR)Mental health, community & social care

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SystematicHQ Denmark · Europe
Electronic health records (EHR/EPR)

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile